Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
from Deutsche Bank issued a price target of $303.00 for PRAX on 2025-12-05 13:37:32.The adjusted price target was set to $303.00.At the time of the announcement, PRAX...
December 5, 2025 PRAX 30.81%
from Wedbush issued a price target of $83.00 for PRAX on 2025-12-05 12:43:26.The adjusted price target was set to $83.00.At the time of the announcement, PRAX was...
December 5, 2025 PRAX 30.81%
from BTIG issued a price target of $499.00 for PRAX on 2025-12-05 12:15:37.The adjusted price target was set to $499.00.At the time of the announcement, PRAX was...
December 5, 2025 PRAX 30.81%
from Craig-Hallum issued a price target of $16.00 for ISSC on 2025-12-05 12:12:18.The adjusted price target was set to $16.00.At the time of the announcement, ISSC was...
December 5, 2025 ISSC 1.80%
James Condulis from Stifel Nicolaus issued a price target of $10.00 for XFOR on 2025-12-05 11:37:33.The adjusted price target was set to $10.00.At the time of the announcement,
December 5, 2025 XFOR 4.47%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| LICN Lichen International Limi | 4.40
50.13% | ||||||||||||||||||
| TORO Toro Corp. | 5.77
39.59% | ||||||||||||||||||
| BZFDW BuzzFeed | 0.04
32.96% | ||||||||||||||||||
| PRAX Praxis Precision Medicine | 248.50
30.81% | ||||||||||||||||||
| CDIOW Cardio Diagnostics Holdin | 0.02
17.38% | ||||||||||||||||||
| CARM Carisma Therapeutics, Inc | 0.06
17.32% | ||||||||||||||||||
| LIVE Live Ventures Incorporate | 11.38
13.86% | ||||||||||||||||||
| MHUA Meihua International Medi | 14.27
13.71% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 5.08%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -3.78%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -0.06%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.12%